...
首页> 外文期刊>Journal of molecular signaling >Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
【24h】

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*

机译:包含蛋白酪氨酸磷酸酶1(SHP-1)的Src同源2(SH2)结构域使VEGF Receptor-2去磷酸化并减弱内皮DNA合成,但不迁移*

获取原文
           

摘要

BackgroundVascular endothelial growth factor receptor-2 (VEGFR-2, KDR), a receptor tyrosine kinase, regulates mitogenic, chemotactic, hyperpermeability, and survival signals in vascular endothelial cells in response to its ligand vascular permeability factor/ vascular endothelial growth factor (VPF/VEGF). SHP-1 is a protein tyrosine phosphatase known to negatively regulate signaling from receptors such as EGF receptor, IL3 receptor, erythropoietin receptor and also KDR. However, the mechanism by which SHP-1 executes KDR dephosphorylation, the targeted tyrosine residue(s) of KDR and also overall downstream signaling or phenotypic change(s) caused, is not defined.ResultsHere, we have demonstrated that KDR and SHP-1 are constitutively associated and upon VEGF treatment, the phosphatase activity of SHP-1 is stimulated in a c-Src kinase dependent manner. Knockdown of SHP-1 by siRNA or inhibition of c-Src by an inhibitor, results in augmented DNA synthesis perhaps due to increased phosphorylation of at least three tyrosine residues of KDR 996, 1059 and 1175. On the other hand, neither tyrosine residue 951 of KDR nor VEGF-mediated migration is affected by modulation of SHP-1 function.ConclusionTaken together our results define the tyrosine residues of KDR that are regulated by SHP-1 and also elucidates a novel feed back loop where SHP-1 is activated upon VEGF treatment through c-Src and controls KDR induced DNA synthesis, eventually leading to controlled angiogenesis.
机译:背景血管内皮生长因子受体2(VEGFR-2,KDR)是一种酪氨酸激酶,可响应配体血管通透性因子/血管内皮生长因子(VPF /)来调节血管内皮细胞的促有丝分裂,趋化性,通透性和存活信号VEGF)。 SHP-1是一种蛋白酪氨酸磷酸酶,已知会负调节来自EGF受体,IL3受体,促红细胞生成素受体以及KDR等受体的信号传导。但是,尚未定义SHP-1执行KDR磷酸化的机制,KDR的靶向酪氨酸残基以及引起整体下游信号传导或表型变化的机制。结果在此证明了KDR和SHP-1 SHP-1是组成性相关的,并且在VEGF处理后,SHP-1的磷酸酶活性以c-Src激酶依赖性方式被刺激。通过siRNA抑制SHP-1或通过抑制剂抑制c-Src,可导致DNA合成增加,这可能是由于KDR 996、1059和1175的至少三个酪氨酸残基的磷酸化增加。另一方面,酪氨酸残基951均没有结论:我们的结果共同定义了受SHP-1调节的KDR酪氨酸残基,并阐明了一种新的反馈环,其中SHP-1被VEGF激活通过c-Src进行治疗并控制KDR诱导的DNA合成,最终导致受控的血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号